APA (7th ed.) Citation

Kentaro Nishi, Masao Ogura, Naotaka Tamai, Naofumi Gima, Kentaro Ide, Goro Koinuma, . . . Shuichi Ito. (2022). Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: A case report and literature review. BMC.

Chicago Style (17th ed.) Citation

Kentaro Nishi, Masao Ogura, Naotaka Tamai, Naofumi Gima, Kentaro Ide, Goro Koinuma, Koichi Kamei, and Shuichi Ito. Successful Rituximab Treatment for Severe Rapidly Progressive Interstitial Lung Disease with Anti-MDA5 Antibody-positive Juvenile Dermatomyositis: A Case Report and Literature Review. BMC, 2022.

MLA (9th ed.) Citation

Kentaro Nishi, et al. Successful Rituximab Treatment for Severe Rapidly Progressive Interstitial Lung Disease with Anti-MDA5 Antibody-positive Juvenile Dermatomyositis: A Case Report and Literature Review. BMC, 2022.